PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C- Submission to the National Institute for Health and Clinical Excellence (NICE)
Abstract
Authors
S.C. Humphreys E.H. Elbasha S.A. Ferrante M. Lion C. O'Regan